John G Ullman & Associates Inc Becton Dickinson & CO Transaction History
John G Ullman & Associates Inc
- $624 Million
- Q2 2025
A detailed history of John G Ullman & Associates Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, John G Ullman & Associates Inc holds 4,125 shares of BDX stock, worth $711,191. This represents 0.11% of its overall portfolio holdings.
Number of Shares
4,125
Previous 29,358
85.95%
Holding current value
$711,191
Previous $6.72 Million
89.44%
% of portfolio
0.11%
Previous 1.12%
Shares
4 transactions
Others Institutions Holding BDX
# of Institutions
1,734Shares Held
257MCall Options Held
3.22MPut Options Held
818K-
Vanguard Group Inc Valley Forge, PA28MShares$4.83 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$3.84 Billion0.12% of portfolio
-
State Street Corp Boston, MA14MShares$2.41 Billion0.14% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$2.17 Billion1.91% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.3MShares$1.95 Billion0.32% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $49.2B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...